Caplin Point Laboratories Management
Management criteria checks 3/4
Caplin Point Laboratories' CEO is Sridhar Ganesan, appointed in Mar 2015, has a tenure of 9.33 years. total yearly compensation is ₹8.70M, comprised of 95.4% salary and 4.6% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth ₹134.47M. The average tenure of the management team and the board of directors is 8.4 years and 6 years respectively.
Key information
Sridhar Ganesan
Chief executive officer
₹8.7m
Total compensation
| CEO salary percentage | 95.4% |
| CEO tenure | 9.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 8.4yrs |
| Board average tenure | 6yrs |
Recent management updates
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Recent updates
Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Apr 29Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?
Mar 24We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt
Mar 11Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?
Feb 26What We Learned About Caplin Point Laboratories' (NSE:CAPLIPOINT) CEO Pay
Feb 14Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Feb 02Can You Imagine How Jubilant Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Feel About Its 105% Share Price Gain?
Jan 21
Does This Valuation Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Imply Investors Are Overpaying?
Jan 09Could The Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Ownership Structure Tell Us Something Useful?
Dec 28Is It Worth Buying Caplin Point Laboratories Limited (NSE:CAPLIPOINT) For Its 0.5% Dividend Yield?
Dec 16We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt
Dec 04Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Nov 21Here's What We Learned About The CEO Pay At Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Nov 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹9m | ₹8m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹6m | ₹5m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹6m | ₹5m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹6m | ₹6m | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹2b |
| Mar 31 2019 | ₹6m | ₹6m | ₹2b |
| Dec 31 2018 | n/a | n/a | ₹2b |
| Sep 30 2018 | n/a | n/a | ₹2b |
| Jun 30 2018 | n/a | n/a | ₹1b |
| Mar 31 2018 | ₹6m | ₹6m | ₹1b |
Compensation vs Market: Sridhar's total compensation ($USD104.24K) is below average for companies of similar size in the Indian market ($USD452.74K).
Compensation vs Earnings: Sridhar's compensation has increased by more than 20% in the past year.
CEO
Sridhar Ganesan (69 yo)
9.3yrs
Tenure
₹8,700,000
Compensation
Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Whole Time Director | 9.3yrs | ₹8.70m | 0.12% ₹ 134.5m | |
| Chief Financial Officer | 8.4yrs | ₹9.70m | 0.020% ₹ 22.4m | |
| Chief Operating Officer | 12.9yrs | ₹1.90m | 11.84% ₹ 13.3b | |
| General Counsel | 1.9yrs | ₹2.30m | no data | |
| Deputy Chief Financial Officer | no data | no data | no data | |
| Head of Marketing - Latam Business | no data | no data | 11.91% ₹ 13.4b | |
| Chief Transformation & Digital Officer | less than a year | no data | no data |
8.4yrs
Average Tenure
Experienced Management: CAPLIPOINT's management team is seasoned and experienced (8.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Whole Time Director | 10.4yrs | ₹8.70m | 0.12% ₹ 134.5m | |
| Non-Executive Non-Independent Chairman | 34.3yrs | no data | 18.64% ₹ 20.9b | |
| Non-Executive Independent Director | 7.7yrs | ₹160.00k | no data | |
| Non-Executive Independent Director | 4.3yrs | ₹100.00k | no data | |
| Non-Executive Independent Director | 1.8yrs | ₹40.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | ₹60.00k | 0.000090% ₹ 101.0k |
6.0yrs
Average Tenure
71.5yo
Average Age
Experienced Board: CAPLIPOINT's board of directors are considered experienced (6 years average tenure).